ArticleThe oncologist2026

Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.

Sara Elena Rebuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.